SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis

Table 6 Univariate analysis of factors influencing overall survival in 402 patients with gastrointestinal stromal tumor

Factor		5-yr OS rate (%)	OS HR (95%CI)	P value
Gender	Male: Female	81.3: 89.2	0.508 (0.221-1.169)	0.111
Age (yr)	≤ 60: > 60	88.9: 80.0	2.186 (0.989-4.832)	0.053
Gastrointestinal bleeding	No: Yes	86.8: 81.2	1.259 (0.559-2.837)	0.578
Primary tumor site	Gastric: Non-gastric	83.0: 86.8	1.143 (0.529-2.470)	0.733
Predominant cell type	Spindle: Epithelioid: Mixed	87.7: 82.4: 88.8	0.935 (0.586-1.491)	0.778
Primary tumor size (cm)	≤ 5: > 5	99.2: 74.0	22.726 (3.079-167.742)	0.0021
Mitotic index (HPFs)	≤ 5/50: 6-10/50: > 10/50	96.5: 83.0: 39.7	4.727 (2.887-7.740)	< 0.0011
NIH stage	Very low: Low: Mid: High	100.0: 100.0: 88.6: 70.3	8.005 (2.365-27.098)	0.0011
SLITRK3 expression	(-): (+): (++): (+++)	100.0: 99.0: 86.7: 57.4	4.164 (2.227-7.786)	< 0.0011

¹Statistically significant (P < 0.01). Mid: Intermediate.